Creating a new wound dressing to speed up healing for diabetic patients
Official title: Engineering the open porous nanofibrous microsphere integrated fibrillar hydrogel for the co-delivery of antibacterial and angiogenic agents aimed at the rapid diabetic wound repair
Funded at Terasaki Institute for Biomedical Innovation · NIH-10873792 · Data updated 2026-11-12
This study is testing a new type of wound dressing made from tiny fibers and a gel that helps diabetic wounds heal faster by keeping them moist and delivering healing ingredients right where they're needed.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Terasaki Institute for Biomedical Innovation NIH-funded |
| Lab location | 1 site (Woodland Hills, UNITED STATES) |
| Project start | July 1, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $476,801 |
| NIH project number | 5R01DK134903-02 |
| Project ID | NIH-10873792 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with diabetic wounds that are slow to heal or at risk of infection.
✕Less likely to help
Patients with non-diabetic wounds or those who do not have chronic wound healing issues may not benefit from this research.
What this research studies
This research focuses on developing an innovative wound dressing made from special nanofibers and a gel that can release healing agents to help diabetic wounds heal faster. The dressing is designed to enhance cell movement and tissue formation, which are crucial for closing wounds effectively. By using advanced techniques to create a porous structure, the dressing aims to provide a moist environment and deliver antibacterial and angiogenic agents directly to the wound site. This approach could significantly improve the healing process for patients with diabetic wounds.
Why it matters
Potential benefit: If successful, this research could lead to faster and more effective healing of diabetic wounds, reducing the risk of complications such as infections and amputations.
How similar studies have gone: Previous research has shown promising results with similar approaches using nanofibrous scaffolds for wound healing, indicating potential for success in this novel application.
Where this research is happening
-
Terasaki Institute for Biomedical Innovation
Woodland Hills, United States Active
Researchers
- Principal investigator: Vitharikunnil John, Johnson — Terasaki Institute for Biomedical Innovation
- Study coordinator: Vitharikunnil John, Johnson
Related research
Other NIH-funded projects on the same topics.
-
Diabetic Foot Ulcer Healing Network at the University of Arizona
A NIH-supported project at the University of Arizona aims to improve healing of diabetic foot ulcers by studying biomarkers and running high-quality clinical trials.
-
Understanding how skin layers coordinate healing after injury
Researchers are studying how different layers of adult skin coordinate rapid healing after injury to prevent infection and chronic wounds.
-
Immunomodulatory therapy to speed up healing after oral cavity injuries in kids
A new approach using a drug called FTY720 aims to improve healing and reduce pain after oral injuries or palate surgery in children.
-
How diabetic wounds let Group B Streptococcus cause infections
Researchers are learning how high blood sugar, immune changes, and other bacteria in diabetic wounds help Group B Streptococcus grow and cause worse infections in people with diabetes.
-
Understanding how skin cells exchange harmful chemicals to cause injury and wound repair
A research project aims to uncover how certain chemical agents damage human skin and what happens in the early stages of blistering and inflammation.
-
Intestinal mucosal wound healing in humans
A patient-friendly look at how the lining of the gut repairs itself after injury and why this matters for conditions like inflammatory bowel disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.